Zurück zum Zitat Hammerstingl C, Lickfett L, Jeong KM, Troatz C, Wedekind JA, Tiemann K, Lüderitz B, Lewalter T (2006) Persistence of iatrogenic atrial septal defect after pulmonary vein isolation—an underestimated risk? Am Heart J 152:362.e1–5CrossRef Hammerstingl C, Lickfett L, Jeong KM, Troatz C, Wedekind JA, Tiemann K, Lüderitz B, Lewalter T (2006) Persistence of iatrogenic atrial septal defect after pulmonary vein isolation—an underestimated risk? Am Heart J 152:362.e1–5CrossRef

Zurück zum Zitat Rillig A, Meyerfeldt U, Birkemeyer R, Treusch F, Kunze M, Jung W (2008) Persistent iatrogenic atrial septal defect after pulmonary vein isolation: incidence and clinical implications. J Interv Card Electrophysiol 22:177–181CrossRef Rillig A, Meyerfeldt U, Birkemeyer R, Treusch F, Kunze M, Jung W (2008) Persistent iatrogenic atrial septal defect after pulmonary vein isolation: incidence and clinical implications. J Interv Card Electrophysiol 22:177–181CrossRef

Zurück zum Zitat McGinty PM, Smith TW, Rogers JH (2011) Transseptal left heart catheterization and the incidence of persistent iatrogenic atrial septal defects. J Interv Cardiol 24:254–263CrossRef McGinty PM, Smith TW, Rogers JH (2011) Transseptal left heart catheterization and the incidence of persistent iatrogenic atrial septal defects. J Interv Cardiol 24:254–263CrossRef

Zurück zum Zitat Alkhouli M, Sarraf M, Zack CJ, Holmes DR, Rihal CS (2016) Iatrogenic atrial septal defect following transseptal cardiac interventions. Int J Cardiol 209:142–148CrossRef Alkhouli M, Sarraf M, Zack CJ, Holmes DR, Rihal CS (2016) Iatrogenic atrial septal defect following transseptal cardiac interventions. Int J Cardiol 209:142–148CrossRef

Zurück zum Zitat Cronin EM, Collier P, Wazni OM, Griffin BP, Jaber WA, Saliba WI (2013) Persistence of atrial septal defect after cryoballoon ablation of atrial fibrillation. J Am Coll Cardiol 62:1491–1492CrossRef Cronin EM, Collier P, Wazni OM, Griffin BP, Jaber WA, Saliba WI (2013) Persistence of atrial septal defect after cryoballoon ablation of atrial fibrillation. J Am Coll Cardiol 62:1491–1492CrossRef

Zurück zum Zitat Naksuk N, Asirvatham SJ (2018) Iatrogenic atrial septal defect: reassurance or inquisitiveness. J Interv Card Electrophysiol 52:137–140CrossRef Naksuk N, Asirvatham SJ (2018) Iatrogenic atrial septal defect: reassurance or inquisitiveness. J Interv Card Electrophysiol 52:137–140CrossRef

Zurück zum Zitat Watanabe T, Miyazaki S, Kajiyama T, Ichijo S, Takagi T, Igarashi M, Nakamura H, Taniguchi H, Hachiya H, Iesaka Y (2018) Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation. Heart Vessels 33:1060–1067CrossRef Watanabe T, Miyazaki S, Kajiyama T, Ichijo S, Takagi T, Igarashi M, Nakamura H, Taniguchi H, Hachiya H, Iesaka Y (2018) Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation. Heart Vessels 33:1060–1067CrossRef

Zurück zum Zitat Faletra F, Scarpini S, Moreo A, Ciliberto GR, Austoni P, Donatelli F, Gordini V (1991) Color Doppler echocardiographic assessment of atrial septal defect size: correlation with surgical measurements. J Am Soc Echocardiogr 4:429–434CrossRef Faletra F, Scarpini S, Moreo A, Ciliberto GR, Austoni P, Donatelli F, Gordini V (1991) Color Doppler echocardiographic assessment of atrial septal defect size: correlation with surgical measurements. J Am Soc Echocardiogr 4:429–434CrossRef

Zurück zum Zitat Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, Lang RM, Rome JJ, Wang Y (2015) American Society of Echocardiography; Society for Cardiac Angiography and Interventions. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 28:910–958CrossRef Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, Lang RM, Rome JJ, Wang Y (2015) American Society of Echocardiography; Society for Cardiac Angiography and Interventions. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 28:910–958CrossRef

Zurück zum Zitat Sohara H, Takeda H, Ueno H, Oda T, Satake S (2009) Feasibility of the radiofrequency hot balloon catheter for isolation of the posterior left atrium and pulmonary veins for the treatment of atrial fibrillation. Circ Arrhythm Electrophysiol 2:225–232CrossRef Sohara H, Takeda H, Ueno H, Oda T, Satake S (2009) Feasibility of the radiofrequency hot balloon catheter for isolation of the posterior left atrium and pulmonary veins for the treatment of atrial fibrillation. Circ Arrhythm Electrophysiol 2:225–232CrossRef

Zurück zum Zitat Yamaguchi Y, Sohara H, Takeda H, Nakamura Y, Ihara M, Higuchi S, Satake S (2015) Long-term results of radiofrequency hot balloon ablation in patients with paroxysmal atrial fibrillation: safety and rhythm outcomes. J Cardiovasc Electrophysiol 26:1298–1306CrossRef Yamaguchi Y, Sohara H, Takeda H, Nakamura Y, Ihara M, Higuchi S, Satake S (2015) Long-term results of radiofrequency hot balloon ablation in patients with paroxysmal atrial fibrillation: safety and rhythm outcomes. J Cardiovasc Electrophysiol 26:1298–1306CrossRef

Zurück zum Zitat Sohara H, Ohe T, Okumura K, Naito S, Hirao K, Shoda M, Kobayashi Y, Yamauchi Y, Yamaguchi Y, Kuwahara T, Hirayama H, YeongHwa C, Kusano K, Kaitani K, Banba K, Fujii S, Kumagai K, Yoshida H, Matsushita M, Satake S, Aonuma K (2016) HotBalloon ablation of the pulmonary veins for paroxysmal AF: a Multicenter Randomized Trial in Japan. J Am Coll Cardiol 68:2747–2757CrossRef Sohara H, Ohe T, Okumura K, Naito S, Hirao K, Shoda M, Kobayashi Y, Yamauchi Y, Yamaguchi Y, Kuwahara T, Hirayama H, YeongHwa C, Kusano K, Kaitani K, Banba K, Fujii S, Kumagai K, Yoshida H, Matsushita M, Satake S, Aonuma K (2016) HotBalloon ablation of the pulmonary veins for paroxysmal AF: a Multicenter Randomized Trial in Japan. J Am Coll Cardiol 68:2747–2757CrossRef

Zurück zum Zitat Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696CrossRef Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696CrossRef

Zurück zum Zitat Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillation. J Am Med Assoc 285:2864–2870CrossRef Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillation. J Am Med Assoc 285:2864–2870CrossRef

Zurück zum Zitat Nakamura Y, Sohara H, Ihara M (2018) Insights into guidewire related complication during HotBalloon ablation in patients with atrial fibrillation: what should we know? J Arrhythm 34:650–652CrossRef Nakamura Y, Sohara H, Ihara M (2018) Insights into guidewire related complication during HotBalloon ablation in patients with atrial fibrillation: what should we know? J Arrhythm 34:650–652CrossRef

Zurück zum Zitat Pape LA, Price JM, Alpert JS, Ockene IS, Weiner BH (1991) Relation of left atrial size to pulmonary capillary wedge pressure in severe mitral regurgitation. Cardiology 78:297–303CrossRef Pape LA, Price JM, Alpert JS, Ockene IS, Weiner BH (1991) Relation of left atrial size to pulmonary capillary wedge pressure in severe mitral regurgitation. Cardiology 78:297–303CrossRef

Zurück zum Zitat Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA (1993) Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction, and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol 22:1972–1982CrossRef Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA (1993) Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction, and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol 22:1972–1982CrossRef

Zurück zum Zitat Scicchitano P, Gesualdo M, Cortese F, Acquaviva T, de Cillis E, Bortone AS, Ciccone MM (2019) Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure. Heart Vessels 34:1499–1508CrossRef Scicchitano P, Gesualdo M, Cortese F, Acquaviva T, de Cillis E, Bortone AS, Ciccone MM (2019) Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure. Heart Vessels 34:1499–1508CrossRef

Zurück zum Zitat Yoshiba S, Kojima T, Oyanagi T, Toda K, Osada Y, Muraji S, Imamura T, Nakano S, Makita S, Kobayashi T, Sumitomo N (2021) Late recovery of the cardiopulmonary exercise capacity after transcatheter amplatzer device closures for atrial septal defects in adults. Heart Vessels 36:710–716CrossRef Yoshiba S, Kojima T, Oyanagi T, Toda K, Osada Y, Muraji S, Imamura T, Nakano S, Makita S, Kobayashi T, Sumitomo N (2021) Late recovery of the cardiopulmonary exercise capacity after transcatheter amplatzer device closures for atrial septal defects in adults. Heart Vessels 36:710–716CrossRef

Zurück zum Zitat Yousuf MA, Haq S, O’Donnell RE, Attari M (2015) Hemodynamically signifcant atrial septal defect after atrial fbrillation ablation: a hole to remember. Heart Rhythm 12:1987–1989CrossRef Yousuf MA, Haq S, O’Donnell RE, Attari M (2015) Hemodynamically signifcant atrial septal defect after atrial fbrillation ablation: a hole to remember. Heart Rhythm 12:1987–1989CrossRef

Zurück zum Zitat Dalen JE, Alpert JS (2016) Cryptogenic strokes and patent foramen ovales: what’s the right treatment? Am J Med 129:1159–1162CrossRef Dalen JE, Alpert JS (2016) Cryptogenic strokes and patent foramen ovales: what’s the right treatment? Am J Med 129:1159–1162CrossRef